arrow_left You’re on the news side, go back to data on Biogen

Latest news about Biogen

15 days ago

There has been 16 news about Biogen in the past from 10 different sources and amongst 2 sections

dataset_white Full dataset

Evolution

Here is the latest:

CNBC News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Read link
Oct 31, 2024
CNBC News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Read link
Aug 13, 2024
Quartz
Biogen is buying up an immune drug developer for $1.8 billion
Read link
May 22, 2024
Quartz
Ozempic hits booze sales, Moderna likes AI, and Biogen's blockbuster drug: Pharma news roundup
Read link
Apr 26, 2024
CNBC News
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Read link
Apr 24, 2024
CNBC News
Stocks making the biggest moves midday: JetBlue Airways, Shopify, Biogen and more
Read link
Feb 13, 2024
Ars Technica
Biogen dumps dubious Alzheimer's drug after profit-killing FDA scandal
Read link
Feb 01, 2024
NBC News
Biogen to stop selling controversial Alzheimer's drug Aduhelm
Read link
Jan 31, 2024
CNBC News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Read link
Jan 31, 2024
The Wall Street Journal
Biogen Quits Controversial Alzheimer's Drug Aduhelm
Read link
Jan 31, 2024

Distribution by section

The coverage span across 2 distinct sections:

Distribution by publisher

There has been 10 publishers reporting on this, here are the top ones:

  • CNBC News (38%)
  • Quartz (12%)
  • Politico (6%)
  • Time (6%)
  • CBS (6%)

Details

This content can be used under the CC BY 4.0 license